Enveric Biosciences to Participate in Upcoming Investor Conferences in April 2022

Enveric Biosciences (NASDAQ: ENVB) announced its participation in three investor conferences in April 2022.

Rhea-AI Summary

Enveric Biosciences (NASDAQ: ENVB) announced its participation in three investor conferences in April 2022. Dr. Joseph Tucker, CEO, will speak at the Benzinga Psychedelics Capital Conference on April 19 at 11:10 a.m. ET in Miami, FL; the Sequire Cannabis & Psychedelic Conference on April 20 at 1:00 p.m. ET virtually; and the KCSA Psychedelics Investor Conference on April 27 at 11:00 a.m. ET, also virtually. Interested attendees can register for these events through the provided links.

Argus Session date unavailable

-2.85% session move Open Argus

Details

News Market Reaction – ENVB

The recorded move for ENVB in the trading session of this news was -2.85%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NAPLES, Fla., April 6, 2022 /PRNewswire/ - Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a neuroscience-focused biotechnology company developing next-generation, psychedelic-inspired mental health medicines, today announced that Dr. Joseph Tucker, Chief Executive Officer of Enveric, will participate in three upcoming investor conferences:

Benzinga Psychedelics Capital Conference 

Date: Tuesday, April 19^th at 11:10 a.m. ET 
Location: Fontainebleau Miami Beach in Miami, FL 
To attend, please register here.

Sequire Cannabis & Psychedelic Conference

Date: Wednesday, April 20^th at 1:00 p.m. ET 
Location: Virtual 
To attend, please register here.

KCSA Psychedelics Investor Conference

Date: Wednesday, April 27^th at 11:00 a.m. ET 
Location: Virtual 
To attend, please register here.

For more information about the conferences, or to schedule a one-on-one meeting with Enveric's management team, please contact your appropriate representative, or send an email to KCSA Strategic Communications at EnvericBio@kcsa.com.

About Enveric Biosciences

Enveric Biosciences, Inc. (NASDAQ: ENVB) is a neuroscience-focused pharmaceutical company developing next-generation, psychedelic-inspired mental health medicines. Enveric's robust pipeline supports drug development from the clinic to commercialization aimed to help millions of patients in need around the world suffering from conditions that include cancer-related distress, PTSD and more. For additional information, please visit www.enveric.com.

View original content:https://www.prnewswire.com/news-releases/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-april-2022-301518595.html

SOURCE Enveric Biosciences

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Enveric Biosciences participating in investor conferences in April 2022?

Enveric Biosciences will participate in three investor conferences: Benzinga Psychedelics Capital Conference on April 19, Sequire Cannabis & Psychedelic Conference on April 20, and KCSA Psychedelics Investor Conference on April 27.

Who is speaking at the upcoming Enveric Biosciences investor conferences?

Dr. Joseph Tucker, the CEO of Enveric Biosciences, will be speaking at the upcoming investor conferences.

Where will the Benzinga Psychedelics Capital Conference take place?

The Benzinga Psychedelics Capital Conference will be held at Fontainebleau Miami Beach in Miami, FL.

How can I register for Enveric Biosciences' investor conferences?

You can register for the investor conferences via the links provided in the press release.

What is the focus of Enveric Biosciences?

Enveric Biosciences focuses on developing next-generation, psychedelic-inspired mental health medicines.